NASHNEXT
LIVE

Serial Number

88839148

Owner

GENFIT

Attorney

Brooks R. Bruneau

Filing Date

Mar 18, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NASHNEXT Trademark

Serial Number: 88839148 • Registration: 6375856

NASHNEXT is a trademark filed by GENFIT on March 18, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GENFIT (44 trademarks)

885 rue Eugene Avinee
Loos 59120 , FR

Entity Type: 03

Trademark Details

Filing Date

March 18, 2020

Registration Date

June 8, 2021

Published for Opposition

March 23, 2021

Goods & Services

Biological research; clinical medical research; computer programming; computer software design for others; Laboratory research services relating to pharmaceuticals in the field of metabolic disorders and liver diseases; industrial research services in the field of pharmaceuticals

Diagnostic preparations for scientific use; Chemical reagents for industrial use, other than for medical or veterinary purpose; Chemical reagents for scientific research purposes

Downloadable software for diagnosis of metabolic disorders and liver diseases and in permitting the transmission and exchange of biological data; scientific and instruments in the nature of laboratory devices for detecting genetic and protein sequences, namely, sequencers, genetic analyser machines, biochips, immunoassays, microfluidic platforms, for detecting genomics/proteomics data, namely, quantitative PCR and readers, for integrating and analyzing the data generated from experimental biology, diseases data and patient clinical data, namely, informatics management system, for recording, quantifying, treating, reproducing, transmitting data, in the field of clinical research and diagnostics of metabolic disorders and liver diseases for use in genetic and enzymatic research

Medical apparatuses for measuring metabolic disorders and liver diseases, non-invasive diagnostic apparatus and instruments for detecting metabolic disorders and liver diseases; Medical diagnostic apparatus, namely, medical devices for diagnosis of metabolic disorders and liver diseases, blood analysis apparatus, DNA and RNA analysis apparatus, gene analyzer, medical devices for measuring the evaluation of metabolic disorders and liver diseases, and blood analysis tools for evaluation of metabolic disorders and liver diseases

Medical analysis services for the diagnosis of liver diseases, metabolic diseases, gastroenterological diseases, inflammatory diseases, immune diseases and cancers; blood sample analysis services; medical assistance services; Medical information in the field of metabolic disorders and liver diseases

Pharmaceutical preparations for the prevention, diagnosis, monitoring and imaging of metabolic disorders and liver diseases; Diagnostic preparations and diagnostic biomarker reagents for medical purposes; Diagnostic tests for medical use, namely, reagents, nucleotide sequences, enzymes, nucleotides for blood testing, reagents kit, chemical product, biomarking agents, blood and blood derived samples, namely, plasma, serum, platelet free samples

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 8, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 8, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 23, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 3, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 18, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2021 CRFA
ASSIGNED TO LIE
Feb 12, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 10, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 10, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 10, 2020 CNRT
ASSIGNED TO EXAMINER
Jun 10, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2020 NWOS
NEW APPLICATION ENTERED
Mar 21, 2020 NWAP